145 related articles for article (PubMed ID: 12232763)
21. Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours.
Dimova I; Raitcheva S; Dimitrov R; Doganov N; Toncheva D
Eur J Cancer; 2006 Mar; 42(5):674-9. PubMed ID: 16458500
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.
Beheshti B; Braude I; Marrano P; Thorner P; Zielenska M; Squire JA
Neoplasia; 2003; 5(1):53-62. PubMed ID: 12659670
[TBL] [Abstract][Full Text] [Related]
23. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
24. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus.
Crook T; Wrede D; Tidy J; Scholefield J; Crawford L; Vousden KH
Oncogene; 1991 Jul; 6(7):1251-7. PubMed ID: 1650445
[TBL] [Abstract][Full Text] [Related]
25. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
Brodeur GM; Seeger RC; Schwab M; Varmus HE; Bishop JM
Science; 1984 Jun; 224(4653):1121-4. PubMed ID: 6719137
[TBL] [Abstract][Full Text] [Related]
26. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
27. MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis.
Iwakawa R; Kohno T; Kato M; Shiraishi K; Tsuta K; Noguchi M; Ogawa S; Yokota J
Clin Cancer Res; 2011 Mar; 17(6):1481-9. PubMed ID: 21148746
[TBL] [Abstract][Full Text] [Related]
28. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
[TBL] [Abstract][Full Text] [Related]
29. [Competitive polymerase chain reaction: a new method for measuring N-myc amplification].
Tornóczky T; Vass J; Kajtár P; Kardos M; Lendvai G; Varga T; Pajor L
Orv Hetil; 2000 Jan; 141(1):27-30. PubMed ID: 10673855
[TBL] [Abstract][Full Text] [Related]
30. Loss of retinoblastoma gene and amplification of N-myc gene in retinoblastoma.
Choi SW; Lee TW; Yang SW; Hong WS; Kim CM; Lee JO
J Korean Med Sci; 1993 Feb; 8(1):73-7. PubMed ID: 8343223
[TBL] [Abstract][Full Text] [Related]
31. Increase in copy number of N-myc in retinoblastomas in comparison with chromosome abnormality.
Sakai K; Tanooka H; Sasaki MS; Ejima Y; Kaneko A
Cancer Genet Cytogenet; 1988 Jan; 30(1):119-26. PubMed ID: 3422037
[TBL] [Abstract][Full Text] [Related]
32. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
33. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma.
Armengol G; Knuutila S; Lluís F; Capellà G; Miró R; Caballín MR
Cancer Genet Cytogenet; 2000 Jan; 116(2):133-41. PubMed ID: 10640145
[TBL] [Abstract][Full Text] [Related]
34. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
35. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
36. c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.
Borg A; Baldetorp B; Fernö M; Olsson H; Sigurdsson H
Int J Cancer; 1992 Jul; 51(5):687-91. PubMed ID: 1612775
[TBL] [Abstract][Full Text] [Related]
37. N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatment.
Livingstone A; Mairs RJ; Russell J; O'Donoghue J; Gaze MN; Wheldon TE
Eur J Cancer; 1994; 30A(3):382-9. PubMed ID: 8204363
[TBL] [Abstract][Full Text] [Related]
38. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
[TBL] [Abstract][Full Text] [Related]
39. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis].
Chassevent A; Bénard J
Bull Cancer; 1997 Mar; 84(3):29-34. PubMed ID: 9207866
[TBL] [Abstract][Full Text] [Related]
40. N-myc oncogene amplification in paediatric tumours.
McQuaid S; O'Meara A
Ir J Med Sci; 1990 Jun; 159(6):172-4. PubMed ID: 2172180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
